ESR1 overexpression is a biomarker of relapse and worse prognosis in stage I endometrioid endometrial carcinoma

ESR1 overexpression is a biomarker of relapse and worse prognosis in stage I endometrioid endometrial carcinoma

Endometrial cancer (EC) is the most common pelvic gynecologic malignancy in developed countries, and its incidence is also increasing in developing countries. Endometrioid endometrial carcinoma (EEC) is the most frequent subtype. EEC is often associated with favorable clinicopathological features an...

Full description

Saved in:
Bibliographic Details
Main Authors: C.B.P. Chaves, P. Nicolau-Neto, T.A. Simão, P.T. de Souza-Santos, A. Bergmann, L. Brewer, F.C.B. Moreira, B.S.B. Reis, M.A.M. Moreira, L.F.R. Pinto
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2025-05-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Endometrial cancer
Early stage
Tumor relapse
Prognosis
ESR1
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2025000100636&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items